Future directions—development of a new technology
Editorial on Full-endoscopic Spine Surgery

Future directions—development of a new technology

Hisashi Koga

Department of Neurosurgery, Iwai FESS Clinic, Iwai Orthopaedic Medical Hospital, Tokyo, Japan

Correspondence to: Hisashi Koga, MD, PhD. Department of Neurosurgery, Iwai FESS Clinic, The head of Education and Training Center, Iwai Orthopaedic Medical Hospital, 8-18-4 Minamikoiwa, Edogawa-ku, Tokyo 133-0056, Japan. Email: hkoga0808@gmail.com.

Provenance and Peer Review: This article was commissioned by the Guest Editors (Hisashi Koga and Alf Giese) for the series “Full-endoscopic Spine Surgery” published in Journal of Spine Surgery. The article was sent for external peer review organized by the Guest Editors and the editorial office.


Submitted Aug 24, 2019. Accepted for publication Oct 09, 2019.

doi: 10.21037/jss.2019.10.05


Discovering a new era in the field of surgery can be challenging. Any advances in the field should not cause a disadvantage to the patients. In the very least, any new procedure should not have an operative outcome inferior to that of the previous standard procedures. Several investigators have already published the outcomes of full-endoscopic lumbar interbody fusion (FELIF) (1-5). However, at the moment FELIF seems to be a premature procedure for several reasons. First, full-endoscopic curettage of disc material and bone grafting tend to be insufficient. Thereby, there is a high probability to occur non-fusion or delay of fusion. Second, in some cases, insertion of an appropriately sized cage is difficult. As the FELIF mechanism is more similar to lateral interbody fusion than to posterior/transforaminal lumbar interbody fusion in terms of less destruction of the facet joint and less decompression of posterior elements, a larger cage is required to obtain an indirect decompression effect for the treatment of patients with lumbar canal stenosis. Third, FELIF is more invasive than the established full-endoscopic spine surgery (FESS) procedures. Surgeons should attempt to solve a patient’s problem by using FESS without fusion. To achieve this, precise preoperative diagnosis is the most important factor. For example, discogenic low back pain should first be treated with annuloplasty. If a patient’s leg pain is due to nerve root compression, surgeons should attempt to decompress the nerve root by using FESS without fusion. Fusion operation should only be applied for patients whose symptoms originate from instability.

To solve the first problem, the development of new equipment for speedy and sufficient curettage of disc material will be key to the application of FELIF. Although an expandable cage (1) or a mesh implant (e.g., OptiMesh) (5) seems to be a possible solution for the second problem, such equipments have potential drawbacks of endoplate damage and subsequent cage subsidence. In any case, the development of new equipment must precede that of new operative procedures. It should not be forgotten that the development of FESS was made possible by the introduction of new equipment such as bipolar coagulators and high-speed drills. I expect that equipment manufacturers will partake in further developments of these new FESS procedures.


Acknowledgments

Funding: None.


Footnote

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/jss.2019.10.05). The series “Full-endoscopic Spine Surgery” was commissioned by the editorial office without any funding or sponsorship. HK served as the unpaid Guest Editor of the series and serves as an unpaid editorial member of Journal of Spine Surgery from October 2018 to October 2020.

Ethical Statement: The author is accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Yang J, Liu C, Hai Y, et al. Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion for the Treatment of Lumbar Spinal Stenosis: Preliminary Report of Seven Cases with 12-Month Follow-Up. Biomed Res Int 2019;2019:3091459.
  2. Osman SG. Endoscopic transforaminal decompression, interbody fusion, and percutaneous pedicle screw implantation of the lumbar spine: A case series report. Int J Spine Surg 2012;6:157-66. [Crossref] [PubMed]
  3. Lee SH, Erken HY, Bae J. Percutaneous Transforaminal Endoscopic Lumbar Interbody Fusion: Clinical and Radiological Results of Mean 46-Month Follow-Up. Biomed Res Int 2017;2017:3731983.
  4. Jacquot F, Gastambide D. Percutaneous endoscopic transforaminal lumbar interbody fusion: is it worth it? Int Orthop 2013;37:1507-10. [Crossref] [PubMed]
  5. Kolcun JPG, Brusko GD, Basil GW, et al. Endoscopic transforaminal lumbar interbody fusion without general anesthesia: operative and clinical outcomes in 100 consecutive patients with a minimum 1-year follow-up. Neurosurg Focus 2019;46:E14. [Crossref] [PubMed]
Cite this article as: Koga H. Future directions—development of a new technology. J Spine Surg 2020;6(2):521-522. doi: 10.21037/jss.2019.10.05